Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
about
Insulin in central nervous system: more than just a peripheral hormoneIntranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidenceMetabolic syndrome and the role of dietary lifestyles in Alzheimer's diseaseGlatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunctionInflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's DiseaseMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalMetabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and TreatmentIntranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentElevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainMitochondria and cardiovascular agingBrain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseRoles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factorsAberrant insulin signaling in Alzheimer's disease: current knowledgeGIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in ratsNeuropathology of type 2 diabetes: a short review on insulin-related mechanismsDiabetes mellitus and cognitive impairmentsAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicityInsulin Regulates the Activity of the High-Affinity Choline Transporter CHTMechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's diseaseDiet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial.Meditation as a therapeutic intervention for adults at risk for Alzheimer's disease - potential benefits and underlying mechanisms.Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols.Type 2 diabetes and Alzheimer's disease: from common pathologies to potential new therapeutics.Ceramide-mediated insulin resistance and impairment of cognitive-motor functionsNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.POTENTIAL NON-GROWTH USES OF rhIGF-IEffect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trialSex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed miceExperimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's diseaseDicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesiaUnraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.
P2860
Q21296648-B1E5B3F5-EB00-447F-82BD-107D09C6D0A9Q24601034-E8F58E61-D28E-4546-8A8E-6D6B770C547AQ24654247-0995D6A9-8588-44F9-A45F-8A80447915BBQ24676445-245148C7-2574-42C6-8297-7E0300D4C75CQ26745936-B18724AE-F844-44DD-92F8-607FA195E7BCQ26773657-122CA08C-C18A-4395-AE8C-A4DDE9DFFFF2Q26783344-40BD1555-85D8-47F6-9AC7-A2F2929EA555Q26799893-96D07BAD-F661-4E09-BABC-83B6F2D1F109Q26830845-B80E39A7-1F7C-4A49-B4DE-2278AB079498Q26860246-31DB9302-EFCC-49C4-9AA7-578E427EF686Q27003253-A47D6228-7F05-4274-A120-4F580C5EC038Q27011752-91E45D98-9BE6-40C3-80D0-C18AD66483D3Q27012801-C548D6F9-C083-4625-96F7-B6090D1A2FD3Q27021700-313D03EA-141C-4E63-863E-7AAA216F673DQ27022694-ED46325D-E252-43FB-AC6E-F4D52629E71AQ27024222-947666EC-EC49-4ED4-AF53-3563A1D8DA7CQ27302985-908AD758-6028-484E-8947-4405CA26EB77Q27694676-D1E1D7B7-78B9-48FE-9E66-CECB81D890C7Q28079459-3D67B975-C5BB-4459-A8F9-5D101109DC7EQ28085139-EE266C09-33A6-46E7-8EF3-4156C8FACDD2Q28259585-7E629A6A-E1A9-4106-8B18-587A93C67598Q28394667-B5A51E9A-2C1D-4EBB-9823-AC3AAFCEA4C1Q28546435-4963E006-9AA3-4156-87FA-2066517FAE31Q28731520-AB378EAF-9D47-44E2-8D21-6BDE73089792Q30052936-3DB89DED-3932-4F73-8A75-5136199C93BCQ30276981-70E7229F-1453-422C-80FE-4855AE34C722Q30413222-478A9672-ED6A-41C2-B405-9A3BBA15863BQ30415477-DFC8FB92-0EA3-48A2-9E61-75671D0DFABEQ30438004-CDF88B66-1DE8-4312-AC32-E4DFDD2865F4Q30478907-202F0B0A-B9E0-446C-870D-8E9351D06DE6Q30484122-E6FB4777-29AA-4001-AAAD-EAAFF5EE06B4Q30492205-BD3F07D3-5B68-4AB2-B28B-798199F1BD42Q30559265-701FDDA3-8BD2-4070-9EDD-2A6874620B23Q30586321-9D01030B-2200-4162-9ECB-C02BFFC70705Q30772562-711EA6A6-BC86-4F7D-B330-EC4E6FCF5FB0Q30913572-8BC68723-6E50-452B-B6A3-00EF68FC8AAAQ33316237-BD32674A-AAD7-47A9-B187-27AD0C37750CQ33362745-660802D7-CCD7-4016-AD9C-B81950B98ED9Q33543381-8D0B3FFE-4FF0-4375-9324-70EAF41325B9Q33581424-56CF4CC9-3599-4B2D-AE53-09D0C0069AB4
P2860
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@ast
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@en
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@nl
type
label
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@ast
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@en
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@nl
prefLabel
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@ast
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@en
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@nl
P2093
P1476
Insulin and insulin-like growt ...... n reductions in acetylcholine.
@en
P2093
Alison Goldin
Enrique J Rivera
Jack R Wands
Noah Fulmer
Rose Tavares
Suzanne M de la Monte
P304
P577
2005-12-01T00:00:00Z